Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

Lam Research stock swings on tariff jitters as UBS lifts target ahead of earnings

New York, Jan 20, 2026, 18:51 EST — After-hours

  • Lam Research closed the regular session down 0.25%, with little movement in after-hours trading
  • Tech shares dipped after renewed tariff warnings rattled the market, stirring volatility among chipmakers
  • UBS lifted its price target for Lam, as investors look ahead to the Jan. 28 earnings report for guidance

Lam Research Corp shares slipped roughly 0.2% in after-hours trading Tuesday, holding close to $222 following a choppy session that ended with little change.

The chip-equipment maker faces a crucial week, with political tensions shaping risk appetite and its earnings report due in eight days. Lam has announced its quarterly financial conference call will take place on Jan. 28.

The date is crucial since Lam provides wafer fabrication equipment—key tools for chip production—and investors often interpret its outlook as a gauge of chipmakers’ appetite for new plants and upgrades.

Wall Street stumbled Tuesday, hit by concerns over U.S. President Donald Trump’s tariff threats targeting Europe. The news spooked investors, driving them away from riskier assets and dragging down tech-focused indexes.

Trump announced that an extra 10% tariff will kick in on Feb. 1 for products from eight European nations, linking the measure to his bid for U.S. control over Greenland.

Lam’s decline was relatively mild compared to others in the sector. Applied Materials slid 2.7%, while inspection-tool specialist KLA tumbled 5.2% during the regular session, MarketWatch data shows.

UBS gave bulls a boost, lifting its price target on Lam to $255 from $200 while maintaining a “Buy” rating. The firm cited ongoing checks that suggest a solid Q2 performance and an optimistic guidance outlook. TipRanks

Shares swung between roughly $217.61 and $226.15 on Tuesday, finally closing close to $222.

A lot can go sideways. A prolonged trade dispute might freeze budgets and throw supply chains into chaos, while even a robust chip cycle can stumble if customers delay their orders. “Geopolitical tensions have dented sentiment and cooled early-year exuberance,” said Nuveen strategist Laura Cooper. Reuters

Investors are keeping an eye on whether the tariff dispute will escalate into wider policy battles, as markets monitor the legal and political fallout from Trump’s trade moves.

Lam’s earnings report and conference call on Jan. 28 will be key. Investors will be listening closely for any shifts in management’s outlook on demand, delivery schedules, and customer spending. This could reshape forecasts for the stock.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Constellation Energy

NASDAQ: CEG 94 / 100
#3 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 92 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

AIG

NYSE: AIG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug
Previous Story

Eli Lilly stock ticks up after FDA “breakthrough” tag for ovarian cancer drug

Bank of America stock slips after $1B employee stock award as credit-card cap deadline bites
Next Story

Bank of America stock slips after $1B employee stock award as credit-card cap deadline bites